| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.008 |